Logo image of NVRO

NEVRO CORP (NVRO) Stock Fundamental Analysis

NYSE:NVRO - New York Stock Exchange, Inc. - US64157F1030 - Common Stock - Currency: USD

5.715  0 (-0.09%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NVRO. NVRO was compared to 189 industry peers in the Health Care Equipment & Supplies industry. NVRO has a bad profitability rating. Also its financial health evaluation is rather negative. NVRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NVRO has reported negative net income.
In the past year NVRO has reported a negative cash flow from operations.
In the past 5 years NVRO reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NVRO reported negative operating cash flow in multiple years.
NVRO Yearly Net Income VS EBIT VS OCF VS FCFNVRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

NVRO has a Return On Assets (-11.64%) which is in line with its industry peers.
NVRO has a Return On Equity of -25.33%. This is comparable to the rest of the industry: NVRO outperforms 57.98% of its industry peers.
Industry RankSector Rank
ROA -11.64%
ROE -25.33%
ROIC N/A
ROA(3y)-12.29%
ROA(5y)-13.9%
ROE(3y)-24.6%
ROE(5y)-28.62%
ROIC(3y)N/A
ROIC(5y)N/A
NVRO Yearly ROA, ROE, ROICNVRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

With a decent Gross Margin value of 68.02%, NVRO is doing good in the industry, outperforming 75.53% of the companies in the same industry.
NVRO's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for NVRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y-0.67%
NVRO Yearly Profit, Operating, Gross MarginsNVRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

NVRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NVRO has more shares outstanding
The number of shares outstanding for NVRO has been increased compared to 5 years ago.
The debt/assets ratio for NVRO is higher compared to a year ago.
NVRO Yearly Shares OutstandingNVRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NVRO Yearly Total Debt VS Total AssetsNVRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

NVRO has an Altman-Z score of -0.39. This is a bad value and indicates that NVRO is not financially healthy and even has some risk of bankruptcy.
NVRO has a Altman-Z score (-0.39) which is comparable to the rest of the industry.
NVRO has a Debt/Equity ratio of 0.81. This is a neutral value indicating NVRO is somewhat dependend on debt financing.
NVRO has a worse Debt to Equity ratio (0.81) than 74.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -0.39
ROIC/WACCN/A
WACC7.08%
NVRO Yearly LT Debt VS Equity VS FCFNVRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

NVRO has a Current Ratio of 5.02. This indicates that NVRO is financially healthy and has no problem in meeting its short term obligations.
NVRO has a Current ratio of 5.02. This is in the better half of the industry: NVRO outperforms 76.06% of its industry peers.
NVRO has a Quick Ratio of 3.76. This indicates that NVRO is financially healthy and has no problem in meeting its short term obligations.
NVRO has a Quick ratio of 3.76. This is in the better half of the industry: NVRO outperforms 73.40% of its industry peers.
Industry RankSector Rank
Current Ratio 5.02
Quick Ratio 3.76
NVRO Yearly Current Assets VS Current LiabilitesNVRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.11% over the past year.
NVRO shows a decrease in Revenue. In the last year, the revenue decreased by -0.86%.
Measured over the past years, NVRO shows a small growth in Revenue. The Revenue has been growing by 1.88% on average per year.
EPS 1Y (TTM)38.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.92%
Revenue 1Y (TTM)-0.86%
Revenue growth 3Y5.51%
Revenue growth 5Y1.88%
Sales Q2Q%-6.69%

3.2 Future

NVRO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.69% yearly.
NVRO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.77% yearly.
EPS Next Y3.56%
EPS Next 2Y1.22%
EPS Next 3Y5.03%
EPS Next 5Y7.69%
Revenue Next Year-4.09%
Revenue Next 2Y-1.82%
Revenue Next 3Y0.12%
Revenue Next 5Y2.77%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVRO Yearly Revenue VS EstimatesNVRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
NVRO Yearly EPS VS EstimatesNVRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NVRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVRO Price Earnings VS Forward Price EarningsNVRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVRO Per share dataNVRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.22%
EPS Next 3Y5.03%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NVRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEVRO CORP

NYSE:NVRO (2/12/2025, 1:47:15 PM)

5.715

0 (-0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)03-04 2025-03-04/amc
Inst Owners96.58%
Inst Owner Change-40.53%
Ins Owners2.07%
Ins Owner Change-0.14%
Market Cap214.14M
Analysts50
Price Target7.86 (37.53%)
Short Float %7.88%
Short Ratio5.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.29%
Min EPS beat(2)24.11%
Max EPS beat(2)50.46%
EPS beat(4)4
Avg EPS beat(4)42.62%
Min EPS beat(4)24.11%
Max EPS beat(4)50.46%
EPS beat(8)7
Avg EPS beat(8)23.61%
EPS beat(12)11
Avg EPS beat(12)213.06%
EPS beat(16)15
Avg EPS beat(16)163.35%
Revenue beat(2)1
Avg Revenue beat(2)-1.39%
Min Revenue beat(2)-4.87%
Max Revenue beat(2)2.09%
Revenue beat(4)3
Avg Revenue beat(4)0.13%
Min Revenue beat(4)-4.87%
Max Revenue beat(4)2.09%
Revenue beat(8)4
Avg Revenue beat(8)0.44%
Revenue beat(12)5
Avg Revenue beat(12)0.08%
Revenue beat(16)7
Avg Revenue beat(16)0%
PT rev (1m)-2.24%
PT rev (3m)-21.28%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-164.04%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)10.72%
Revenue NQ rev (1m)1.2%
Revenue NQ rev (3m)-17.68%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 1.02
EV/EBITDA N/A
EPS(TTM)-1.77
EYN/A
EPS(NY)-2.51
Fwd EYN/A
FCF(TTM)-1.51
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS11.19
BVpS7.3
TBVpS5.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.64%
ROE -25.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.02%
FCFM N/A
ROA(3y)-12.29%
ROA(5y)-13.9%
ROE(3y)-24.6%
ROE(5y)-28.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y-0.67%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.81%
Cap/Sales 2.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.02
Quick Ratio 3.76
Altman-Z -0.39
F-Score4
WACC7.08%
ROIC/WACCN/A
Cap/Depr(3y)165.59%
Cap/Depr(5y)139.75%
Cap/Sales(3y)2.36%
Cap/Sales(5y)1.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.92%
EPS Next Y3.56%
EPS Next 2Y1.22%
EPS Next 3Y5.03%
EPS Next 5Y7.69%
Revenue 1Y (TTM)-0.86%
Revenue growth 3Y5.51%
Revenue growth 5Y1.88%
Sales Q2Q%-6.69%
Revenue Next Year-4.09%
Revenue Next 2Y-1.82%
Revenue Next 3Y0.12%
Revenue Next 5Y2.77%
EBIT growth 1Y18.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.72%
EBIT Next 3Y26.72%
EBIT Next 5Y18.34%
FCF growth 1Y-452.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-304.68%
OCF growth 3YN/A
OCF growth 5YN/A